Chapter 1. Global Extractable and Leachable Testing Services Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objectives
1.11.1. Objective - 1
1.11.2. Objective - 2
Chapter 2. Global Extractable and Leachable Testing Services Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Global Extractable and Leachable Testing Services Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.3. Market Drivers Analysis
3.3.1. Supportive regulatory framework and rising emphasis on patient safety
3.3.2. Growing pharmaceutical and biotechnology industry
3.3.3. Widespread adoption of single-use technology
3.4. Market Restraint Analysis
3.4.1. Complexity associated with extractable and leachable testing
3.5. Industry Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTLE Analysis
3.5.3. COVID-19 Impact Analysis: Global Extractable and Leachable Testing Services Market
Chapter 4. Global Extractable and Leachable Testing Services Market: Product Type Estimates & Trend Analysis
4.1. Global Extractable and Leachable Testing Services Market: Product Type Movement Analysis
4.2. Container Closure Systems
4.2.1. Container Closure Systems Market Estimates and Forecasts, (2025-2033)
4.3. Single-use Systems
4.3.1. Single-use Systems Market Estimates and Forecasts, (2025-2033)
4.4. Drug Delivery Systems
4.4.1. Drug Delivery Systems Market Estimates and Forecasts, (2025-2033)
4.5. Others
4.5.1. Others Market Estimates and Forecasts, (2025-2033)
Chapter 5. Global Extractable and Leachable Testing Services Market: Application Estimates & Trend Analysis
5.1. Global Extractable and Leachable Testing Services Market: Application Movement Analysis
5.2. Parenteral Drug Products
5.2.1. Parenteral Drug Products Market Revenue Estimates and Forecasts, (2025-2033)
5.3. Orally Inhaled and Nasal Drug Products
5.3.1. Orally Inhaled and Nasal Drug Products Market Revenue Estimates and Forecasts, (2025-2033)
5.4. Ophthalmic
5.4.1. Ophthalmic Market Revenue Estimates and Forecasts, (2025-2033)
Chapter 6. Global Extractable and Leachable Testing Services Market: Regional Business Analysis
6.1. Regional Market Snapshot
6.2. North America
6.2.1. North America Extractable and Leachable Testing Services Market, (2025-2033)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. U.S. Extractable and Leachable Testing Services Market, (2025-2033)
6.2.2.3. Competitive Scenario
6.2.2.4. Regulatory Framework
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Canada Extractable and Leachable Testing Services Market, (2025-2033)
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.3. Europe
6.3.1. Europe Extractable and Leachable Testing Services Market, (2025-2033)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. UK Extractable and Leachable Testing Services Market, (2025-2033)
6.3.2.3. Competitive Scenario
6.3.2.4. Regulatory Framework
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Germany Extractable and Leachable Testing Services Market, (2025-2033)
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.4. Spain
6.3.4.1. Key Country Dynamics
6.3.4.2. Spain Extractable and Leachable Testing Services Market, (2025-2033)
6.3.4.3. Regulatory Framework
6.3.4.4. Competitive Scenario
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. France Extractable and Leachable Testing Services Market, (2025-2033)
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Italy Extractable and Leachable Testing Services Market, (2025-2033)
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Denmark Extractable and Leachable Testing Services Market, (2025-2033)
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Sweden Extractable and Leachable Testing Services Market, (2025-2033)
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Norway Extractable and Leachable Testing Services Market, (2025-2033)
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.4. Asia Pacific
6.4.1. Asia Pacific Extractable and Leachable Testing Services Market, (2025-2033)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Japan Extractable and Leachable Testing Services Market, (2025-2033)
6.4.2.3. Competitive Scenario
6.4.2.4. Regulatory Framework
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. China Extractable and Leachable Testing Services Market, (2025-2033)
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. India Extractable and Leachable Testing Services Market, (2025-2033)
6.4.4.3. Regulatory Framework
6.4.4.4. Competitive Scenario
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Australia Extractable and Leachable Testing Services Market, (2025-2033)
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.6. South Korea
6.4.6.1. Key Country Dynamics
6.4.6.2. South Korea Extractable and Leachable Testing Services Market, (2025-2033)
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Thailand Extractable and Leachable Testing Services Market, (2025-2033)
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.5. Latin America
6.5.1. Latin America Extractable and Leachable Testing Services Market, (2025-2033)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Brazil Extractable and Leachable Testing Services Market, (2025-2033)
6.5.2.3. Competitive Scenario
6.5.2.4. Regulatory Framework
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Mexico Extractable and Leachable Testing Services Market, (2025-2033)
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Argentina Extractable and Leachable Testing Services Market, (2025-2033)
6.5.4.3. Regulatory Framework
6.5.4.4. Competitive Scenario
6.6. MEA
6.6.1. MEA Extractable and Leachable Testing Services Market, (2025-2033)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. South Africa Extractable and Leachable Testing Services Market, (2025-2033)
6.6.2.3. Competitive Scenario
6.6.2.4. Regulatory Framework
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Saudi Arabia Extractable and Leachable Testing Services Market, (2025-2033)
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. UAE Extractable and Leachable Testing Services Market, (2025-2033)
6.6.4.3. Regulatory Framework
6.6.4.4. Competitive Scenario
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Kuwait Extractable and Leachable Testing Services Market, (2025-2033)
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
Chapter 7. Global Extractable and Leachable Testing Services Market: Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. Service Launch
7.2.2. Partnerships & Collaboration
7.2.3. Expansions
7.2.4. Acquisition
7.2.5. Others
7.3. Key Company Market Share Analysis, 2022
7.4. Company Profiles
7.4.1. Intertek Group plc
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Thermo Fisher Scientific
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Medical Engineering Technologies Ltd.
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Eurofins Scientific
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. SCHOTT Pharma
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Nelson Labs
7.4.6.1. Company Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. SGS S.A.
7.4.7.1. Company Overview
7.4.7.2. Product Benchmarking
7.4.7.3. Strategic Initiatives
7.4.8. Sartorius AG
7.4.8.1. Company Overview
7.4.8.2. Product Benchmarking
7.4.8.3. Strategic Initiatives
7.4.9. Analytica Chemie Inc.
7.4.9.1. Company Overview
7.4.9.2. Product Benchmarking
7.4.9.3. Strategic Initiatives
7.4.10. Auriga Research Pvt. Ltd.
7.4.10.1. Company Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Merck Millipore
7.4.11.1. Company Overview
7.4.11.2. Product Benchmarking
7.4.11.3. Strategic Initiatives
7.4.12. Dalton Pharma Services
7.4.12.1. Company Overview
7.4.12.2. Product Benchmarking
7.4.12.3. Strategic Initiatives
7.4.13. Gateway Analytical
7.4.13.1. Company Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Strategic Initiatives
著作権 ©2022 無断複写・転載を禁じます
